← Evidence map

ReviewFrontiers in immunology2026

Gut microbiota-driven immunomodulation in tuberculosis: targeting dysbiosis to overcome drug resistance.

Qi Nie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42630573